{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-185382","form_type":"8-K","ticker":"KALV","cik":"0001348911","company_name":"KalVista Pharmaceuticals, Inc.","filed_at":"2025-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.794875+00:00","generated_at":"2026-05-17T10:46:57.238712+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"KalVista sets June 18, 2026 as annual meeting date; stockholder deadlines revised","bullets":["2026 Annual Meeting set for June 18, 2026; changed >30 days from 2025 meeting.","Stockholder proposals for proxy inclusion due January 6, 2026.","Other proposals or director nominations due August 31, 2025 (10 days after this 8-K).","Universal proxy rule compliance required for soliciting proxies in support of non-company nominees.","Advance notice procedures per Bylaws apply; notice to Cambridge, MA address."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-185382","json":"https://secwatch.observer/filing/0001193125-25-185382.json","markdown":"https://secwatch.observer/filing/0001193125-25-185382.md","text":"https://secwatch.observer/filing/0001193125-25-185382.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348911/000119312525185382/0001193125-25-185382-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348911/000119312525185382/d928596d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:46:57.238712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}